GOLDMAN SACHS GROUP INC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 6 filers reported holding VIKING THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,582,101
-41.4%
594,589
-14.2%
0.00%
-50.0%
Q2 2023$11,231,293
-22.5%
692,862
-20.4%
0.00%
-33.3%
Q1 2023$14,485,267
+1833.0%
869,986
+991.3%
0.00%
Q4 2022$749,368
+641.9%
79,720
+115.3%
0.00%
Q3 2022$101,000
-39.2%
37,035
-35.4%
0.00%
Q2 2022$166,000
-78.7%
57,357
-78.0%
0.00%
Q1 2022$781,000
+95.2%
260,349
+199.3%
0.00%
Q4 2021$400,000
-54.7%
86,997
-38.1%
0.00%
Q3 2021$883,000
-49.5%
140,611
-51.8%
0.00%
Q2 2021$1,749,000
+464.2%
291,981
+495.4%
0.00%
Q1 2021$310,000
-29.2%
49,043
-36.9%
0.00%
Q4 2020$438,000
-88.0%
77,770
-87.6%
0.00%
-100.0%
Q3 2020$3,638,000
-12.4%
625,024
+8.5%
0.00%0.0%
Q2 2020$4,154,000
+967.9%
576,154
+592.6%
0.00%
Q1 2020$389,000
-66.0%
83,189
-41.7%
0.00%
Q4 2019$1,145,000
+74.3%
142,755
+49.4%
0.00%
Q3 2019$657,000
+170.4%
95,542
+226.7%
0.00%
Q2 2019$243,000
-62.5%
29,244
-55.1%
0.00%
Q1 2019$648,000
-61.6%
65,195
-70.4%
0.00%
-100.0%
Q4 2018$1,687,000
-7.5%
220,448
+110.5%
0.00%
Q3 2018$1,824,000
+67.0%
104,739
-9.0%
0.00%
Q2 2018$1,092,000
+18.2%
115,096
-45.6%
0.00%
Q1 2018$924,000
+2540.0%
211,429
+623.1%
0.00%
Q4 2016$35,000
-20.5%
29,239
+128.0%
0.00%
Q4 2015$44,000
-58.9%
12,826
-29.8%
0.00%
Q3 2015$107,000
-36.7%
18,262
-22.9%
0.00%
Q2 2015$169,00023,6940.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 250,000$2,005,0005.90%
Sio Capital Management, LLC 731,453$5,866,0001.40%
KNOTT DAVID M 218,102$1,749,0000.71%
ArrowMark Colorado Holdings LLC 8,813,578$70,685,0000.63%
DAFNA Capital Management LLC 209,200$1,678,0000.58%
Park West Asset Management LLC 1,545,075$12,391,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 590,000$4,732,0000.39%
Cornerstone Capital, Inc. 245,796$1,971,0000.28%
Ikarian Capital, LLC 150,000$1,203,0000.20%
Ikarian Capital, LLC 150,000$1,203,0000.20%
View complete list of VIKING THERAPEUTICS INC shareholders